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Introduction
Endometrial cancer represents a significant health issue for women in developed countries and its incidence is still rising (1). Advanced age and an oversupply of endogenous or exogenous oestrogen are the most common and well established risk factors for endometrial cancer and patients often receive treatment for obesity, diabetes mellitus and hypertension (2) (3) (4) (5) . Treatment of endometrial cancer is primarily surgical, generally yielding excellent survival outcomes (6) .
Traditionally, surgery has been performed through a laparotomy (Total Abdominal Hysterectomy; TAH), which is associated with significant morbidity. Results from our randomized controlled trial comparing TAH with total laparoscopic hysterectomy (TLH) (the LACE trial) found that patients undergoing TLH reported significantly better postsurgical improvement in Quality of Life (QoL) compared to TAH (7) . This improvement in QoL continued to favour a laparoscopic approach for up to 6 months post-surgery. Previous findings from the US Gynecologic Oncology Group (GOG) LAP2 trial suggest a lower incidence of surgical adverse events (AEs) in uterine cancer patients who received laparoscopic compared to open surgery (8) . In contrast, the recently published Dutch TLH trial suggested a similar rate of surgical complications in laparoscopic and open surgery for early endometrial cancer and endometrial hyperplasia with atypia (9) .
In this issue, we have reported that the incidence of AEs was significantly reduced in patients receiving TLH compared to TAH (Obermair et al, submitted for publication). The results suggest that the surgical approach is a potentially modifiable risk factor for AEs, but the risk factors leading to surgical complications are largely unknown.
Therefore, it was the aim of this manuscript to identify the risk factors associated with AEs in patients undergoing surgery for apparent early stage endometrial cancer. In addition, we developed a nomogram to predict a patient's individual risk to develop a major AE based on pre-surgical characteristics.
Patients and Methods
Between October 2005 and June 2010, a total of 760 women with apparent stage I endometrial cancer was enrolled into the LACE trial (clinicaltrials.gov id: NCT00096408).
Its study design, data on early surgical recovery and postoperative QoL as well as data on the surgical safety of TLH were reported previously (7, 10) . In brief, patients were randomized to either TLH or TAH using stratified permuted blocks through a web-based system with concealment of the next allocated treatment to study staff. Ethical clearance was obtained from all the relevant hospitals where patients were recruited and all the patients had provided written informed consent.
Women were eligible if they had histologically confirmed endometrioid endometrial adenocarcinoma (irrespective of histological grade), disease apparently confined to the uterus and ECOG performance status of zero or one. Patients had to have medical imaging of the pelvis, abdomen and the chest to suggest the absence of extrauterine disease. Patients had a comprehensive surgical staging except those with grade 1 or grade 2 tumours with myometrial invasion up to the inner half, patients who were unfit for a lymph node dissection because of medical reasons or morbidly obese patients. All trial surgeons had to go through an accreditation process to ensure the highest possible surgical standard. The surgical technique was described in detail previously (11) .
A comprehensive surgical and medical history was taken prior to surgery. Medical Comorbidities were recorded, classified and scored according to Charlson et al (12) . Patients also completed questionnaires on relevant social and demographic variables. Patients were followed-up for at least 6 weeks for any adverse event. Post-operative adverse events (AEs) were recorded using the NCI Common Terminology Criteria for Adverse Events v3.0 (CTC AE). Serious AEs were defined as any event that resulted in death, was immediately life threatening, required inpatient hospitalization or prolongation of an existing hospitalization or that resulted in persistent or significant disability/incapacity. All serious AEs were reviewed by an independent safety committee. All the AEs were managed by respective clinicians/coinvestigators as per their local guidelines and patients were followed-up until satisfactory resolution or until the principal investigator or co-investigator deemed the event to be chronic or the patient was assessed to be stable. A "major AE" was defined as either a postoperative AE of CTC Grade 3+ and/or a serious AE as defined above. For the aim of this analysis, the incidence of a "major AE" was considered an endpoint.
Statistical analyses
Patients who had completed at least 6 weeks of follow-up after surgery were included.
Univariate logistic regression analysis was used to test for associations between the incidence of major AEs and relevant clinical and demographic factors. Due to the skewed distribution of CA-125, neutrophil count, bilirubin and alanine transaminase (ALT), these variables were log (natural) transformed and evaluated. Variables that showed significant association with major AEs were used in a multivariate logistic regression with stepwise model selection.
Risk-factors were also evaluated for significant interactions. Height and or weight were missing for 27 patients (3.5%) and these patients were excluded in multivariate models that utilized body mass index as a predictor. No data were imputed. Treatment effects were analysed according to the intention to treat principle.
A nomogram was developed to predict the risk of major AEs within 6 weeks of surgery using the entire dataset. The following variables available prior to surgery formed part of the 
Results
A total of 760 patients were enrolled in the LACE trial between 2005 and 2010. Of these, four patients withdrew after randomization but prior to surgery and an additional three patients withdrew from the trial one week after surgery. Of a total of 753 evaluable patients with at least 6 weeks of follow-up, 349 were randomly allocated to treatment with TAH, and 404 to treatment with TLH. Treatment groups were balanced in terms of relevant demographic and clinical factors and descriptive AE data are also shown elsewhere (Obermair et al, submitted for publication in this issue). A total of 117 (15%) patients had at least one post-operative AE with CTC Grade 3+, and 83 (11%) patients had at least one serious AE. One hundred and thirty two patients (17%) had a major AE.
Univariate logistic regression analysis showed that allocation to TAH, increasing Charlson's comorbidity score, increasing BMI, increasing ECOG performance score, higher grade of curettings, low baseline haemoglobin levels and elevated aspartate transaminase levels were associated with risk of a major AE, while age at diagnosis, and other blood status factors did not attain statistical significance (Table 2) .
On multivariable analysis, treatment allocation to TAH, increasing Charlson's medical comorbidity score, poor grade of differentiation on curettings (FIGO grade 2 or 3), high BMI and low preoperative haemoglobin level remained independently significant for major AEs (p<0.05). Figure 1 shows the nomogram to predict major AEs. To allow risk prediction, points were allocated to each of the predictor variables. The sum of all the points for a patient corresponds to a predicted probability of a major AE. Initial modelling showed a concordance index of 0.68. Internal validation with 1000 bootstrap resamples showed our model to overpredict by 4.5%. The model was recalibrated and achieved a bias-corrected concordance index of 0.65 for predicting a major AE. 
Discussion
We present a simple algorithm in the form of a nomogram to estimate an individual patient's risk of developing a major surgical AE following TLH or TAH for apparent early endometrial cancer prior to surgery. Parameters available before surgery and found to be independently associated with an increased risk of major AE in patients presenting with apparently stage I endometrial cancer include an open surgical approach through laparotomy, a higher Charlson's medical co-morbidity score at baseline, advanced FIGO grade of curettings, higher BMI and low haemoglobin levels prior to surgery.
Adverse events during or following a surgical procedure are not uncommon, especially in high risk specialties such as surgical oncology. The published incidence of adverse events among patients with gynaecological cancer varies from 26% to 54% (13, 14) and some studies suggest that a significant portion of AEs are preventable (15) (16) (17) .
The present manuscript suggests that major AEs are partly predictable. The planned surgical approach was one of the potentially modifiable risk factors. Choosing a laparoscopic approach to surgery for endometrial cancer reduced the risk of major surgical AEs by at least 46% after adjusting for other prognostic factors. Moderately differentiated curettings and low preoperative haemoglobin independently contributed to the risk of major AEs. The preoperative ECOG performance status was also included in the model but only scarce literature is available on the role of ECOG performance status and its impact on the risk of surgical adverse events in endometrial cancer. However, performance status has been shown to be related to clinical outcomes including survival in other cancers (18) (19) (20) (21) (22) (23) (24) .
Obesity was reported to be a risk factor for postoperative AEs previously, especially in patients who require a laparotomy (25, 26) . In the Dutch TLH trial (9), increasing age and BMI were significantly associated with an increased risk of major complications regardless of the surgical approach. In the LACE trial, higher BMI increased the risk for major AEs. size less than 10 weeks gestation and had to be fit for surgery with an ECOG score of not higher than 1. Therefore, our prediction model is not applicable to patients presenting with advanced stage endometrial cancer or to patients with poor preoperative ECOG performance score, and also needs to be validated on an independent dataset to confirm its utility. Finally, the risk prediction tool developed within the present study still needs to be validated on an independent sample.
In summary, our manuscript offers a new approach to quantifying the risk for major AEs in individual patients who require surgery for apparent early-stage endometrial cancer. These findings may allow gynecological oncologists to better predict the probability of major AEs in individual patients. In the future, the nomogram may also be used for comparison of risk adjusted adverse outcomes between health care institutions and also over time within the same institution.
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